Chemotherapy dosing part II: alternative approaches and future prospects.
1Department of Pharmacy and Pharmacology, 5W, University of Bath, Claverton Down, Bath BA2 7AY, UK.
Part II explores alternative chemotherapy dosing strategies beyond current practices. It examines therapeutic drug monitoring, pharmacokinetic-pharmacodynamic relationships, and Bayesian modeling for improved patient outcomes.
Area of Science:
- Oncology
- Pharmacology
- Clinical Pharmacy
Background:
- Current chemotherapy dosing lacks robust scientific evidence.
- Part I highlighted existing practices and their limitations.
Purpose of the Study:
- To discuss alternative chemotherapy dosing strategies.
- To evaluate the scientific rationale and practical application of these methods.
Main Methods:
- Review of alternative dosing approaches.
- Discussion of therapeutic drug monitoring.
- Exploration of pharmacokinetic-pharmacodynamic (PK/PD) relationships.
- Analysis of flat-fixed dosing, Bayesian modeling, and dose banding.
Main Results:
- Alternative strategies offer potential improvements over current practices.
- Therapeutic drug monitoring allows for personalized dosing.
- PK/PD relationships link drug exposure to clinical effect.
- Bayesian modeling and dose banding provide structured approaches.
Conclusions:
- Evidence-based alternative dosing methods are crucial for optimizing chemotherapy.
- Implementing these strategies can enhance treatment efficacy and safety.
- Further research is needed to validate and refine these approaches.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Dosage Regimens: Designs and Approaches
